Analyses of human liver samples from patients with NASH or NASH-related HCC showed an elevated expression of the elongase ELOVL6, which is responsible for the elongation of C16 fatty acids. Here, ELOVL6 is linked to metabolic dysfunction-associated steatohepatitis.